Evidence that 5‐lipoxygenase and acetylated cyclooxygenase 2‐derived eicosanoids regulate leukocyte–endothelial adherence in response to aspirin
Open Access
- 1 August 2003
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 139 (7) , 1351-1359
- https://doi.org/10.1038/sj.bjp.0705356
Abstract
Unlike other nonsteroidal anti‐inflammatory drugs that inhibit formation of cyclooxygenase (COX)‐dependent eicosanoids, acetylation of COX‐2 by aspirin switches eicosanoid biosynthesis from prostaglandin E2 (PGE2) to 15‐epi‐lipoxin A4 (15‐epi‐LXA4 or aspirin‐triggered lipoxin, ATL). ATL formation by activated leukocytes (PMN) requires the intervention of 5‐lipoxygenase (5‐LOX), an enzyme that is involved in leukotriene B4 (LTB4) formation. In the present study, we have examined the role of acetylated COX‐2 and 5‐LOX in modulating antiadhesive effects of aspirin on adhesion of PMN to endotoxin (LPS)‐primed human umbilical endothelial cells (HUVEC). Treating PMN/HUVEC cocultures with aspirin resulted in a concentration‐dependent inhibition of cell‐to‐cell adhesion induced by LPS. Treating HUVEC with selective COX‐2 inhibitors, celecoxib and rofecoxib, caused an ∼70% reversion of antiadhesive effect of aspirin. In contrast, inhibition of neutrophil's 5‐LOX pathway with 1 μM ZD2138, a selective 5‐LOX inhibitor, 1 μM BAY‐X‐1005, a FLAP inhibitor, or 100 μM licofelone, a dual COX/5‐LOX inhibitor, did not affect antiadhesive properties of aspirin. Exposure to celecoxib (100 μM) or rofecoxib (10 μM) completely suppressed ATL formation caused by aspirin without affecting LTB4 levels. ZD2138, licofelone and BAY‐X‐1005 inhibited ATL formation as well as LTB4 generation. Treatment with LXA4 reduced PMN adhesion to HUVEC and counteracted the proadhesive effect of celecoxib. In contrast, exposure to Boc‐1, an LXA4 antagonist, counteracts the antiadhesive activities of aspirin. Exposure to U75302, an LTB4 receptor antagonist, enhances the antiadesive effect of aspirin. Reversal of antiadhesive activities of aspirin by celecoxib was associated with increased expression of LFA‐1 on PMN and E‐selectin on HUVEC. Addition of LXA4, ZD2138 and U75302 inhibited these changes. The present results support the notion that inhibition of ATL formation is mechanistically linked to the reversal of the antiadhesive activity of aspirin caused by selective COX‐1 inhibitors and suggests that the LTB4/ATL balance modulates pro‐ and antiadhesive activity of nonsteroidal anti‐inflammatory drugs at the leukocyte–endothelial cell interface. British Journal of Pharmacology (2003) 139, 1351–1359. doi:10.1038/sj.bjp.0705356Keywords
This publication has 37 references indexed in Scilit:
- Aspirin (ASA) regulates 5‐lipoxygenase activity and peroxisome proliferator‐activated receptor α‐mediated CINC‐1 release in rat liver cells: novel actions of lipoxin A4(LXA4) and ASA‐triggered 15‐epi‐LXA4The FASEB Journal, 2002
- Prostaglandins and Leukotrienes: Advances in Eicosanoid BiologyScience, 2001
- Involvement of the Receptor for Formylated Peptides in the in Vivo Anti-Migratory Actions of Annexin 1 and its MimeticsThe American Journal of Pathology, 2001
- Selectivity of Recombinant Human Leukotriene D4, Leukotriene B4, and Lipoxin A4 Receptors with Aspirin-Triggered 15-epi-LXA4 and Regulation of Vascular and Inflammatory ResponsesThe American Journal of Pathology, 2001
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs.Journal of Clinical Investigation, 1998
- Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.Journal of Clinical Investigation, 1998
- Lipoxin A4 Receptor Activation Is Distinct from That of the Formyl Peptide Receptor in Myeloid Cells: Inhibition of CD11/18 Expression by Lipoxin A4-Lipoxin A4 Receptor InteractionBiochemistry, 1995
- Lipoxin generation by permeabilized human plateletsBiochemistry, 1992
- Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological EffectsScience, 1987